Fulcrum Therapeutics Stock Price on December 23, 2024
| FULC Stock | USD 4.89 0.03 0.61% |
Below is the normalized historical share price chart for Fulcrum Therapeutics extending back to July 18, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Fulcrum Therapeutics stands at 4.89, as last reported on the 8th of January, with the highest price reaching 5.06 and the lowest price hitting 4.75 during the day.
If you're considering investing in Fulcrum Stock, it is important to understand the factors that can impact its price. Fulcrum Therapeutics appears to be relatively risky, given 3 months investment horizon. Fulcrum Therapeutics secures Sharpe Ratio (or Efficiency) of 0.17, which denotes the company had a 0.17% return per unit of risk over the last 3 months. By reviewing Fulcrum Therapeutics' technical indicators, you can evaluate if the expected return of 0.76% is justified by implied risk. Please utilize Fulcrum Therapeutics' Downside Deviation of 4.04, mean deviation of 3.44, and Coefficient Of Variation of 969.37 to check if our risk estimates are consistent with your expectations.
At present, Fulcrum Therapeutics' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 899.5 M, whereas Total Stockholder Equity is forecasted to decline to about 142.3 M. . At present, Fulcrum Therapeutics' Price Earnings To Growth Ratio is projected to slightly decrease based on the last few years of reporting. The current year's Price Sales Ratio is expected to grow to 139.42, whereas Price Earnings Ratio is forecasted to decline to (4.02). Fulcrum Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 18th of July 2019 | 200 Day MA 6.3235 | 50 Day MA 3.7797 | Beta 2.235 |
Fulcrum |
Sharpe Ratio = 0.1716
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | FULC | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.4 actual daily | 39 61% of assets are more volatile |
Expected Return
| 0.76 actual daily | 15 85% of assets have higher returns |
Risk-Adjusted Return
| 0.17 actual daily | 13 87% of assets perform better |
Based on monthly moving average Fulcrum Therapeutics is performing at about 13% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Fulcrum Therapeutics by adding it to a well-diversified portfolio.
Price Book 1.065 | Enterprise Value Ebitda (3.09) | Price Sales 3.251 | Shares Float 40.4 M | Wall Street Target Price 5.2857 |
Related Headline
RAPT Therapeutics Headline on 23rd of December 2024
RAPT Therapeutics and Shanghai Jemincare Pharmaceutical Anno... by gurufocus.com
- RAPT obtains worldwide rights excluding China - - Jemincare receives 35 million upfront payment, up to 672.5 million in milestone payments and high singl
Fulcrum Therapeutics Valuation on December 23, 2024
It is possible to determine the worth of Fulcrum Therapeutics on a given historical date. On December 23, 2024 Fulcrum was worth 4.37 at the beginning of the trading date compared to the closed value of 4.68. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Fulcrum Therapeutics stock. Still, in general, we apply an absolute valuation method to find Fulcrum Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Fulcrum Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Fulcrum Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 3.99 | 4.39 | 3.96 | 4.35 | 3,277,668 | |
12/23/2024 | 4.37 | 5.02 | 4.26 | 4.68 | 3,404,251 |
| 4.70 | 4.82 | 4.35 | 4.55 | 729,741 |
| Backtest Fulcrum Therapeutics | | | Fulcrum Therapeutics History | | | Fulcrum Therapeutics Valuation | Previous | Next |
Fulcrum Therapeutics Trading Date Momentum on December 23, 2024
| On December 24 2024 Fulcrum Therapeutics was traded for 4.55 at the closing time. The top price for the day was 4.82 and the lowest listed price was 4.35 . The trading volume for the day was 729.7 K. The trading history from December 24, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 2.78% . The overall trading delta against the current closing price is 2.56% . |
Fulcrum Therapeutics Fundamentals Correlations and Trends
By evaluating Fulcrum Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Fulcrum Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Fulcrum financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Fulcrum Therapeutics Stock history
Fulcrum Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Fulcrum is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Fulcrum Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Fulcrum Therapeutics stock prices may prove useful in developing a viable investing in Fulcrum Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 70.5 M | 74 M | |
| Net Loss | -98.9 M | -103.8 M |
Fulcrum Therapeutics Quarterly Net Working Capital |
|
Fulcrum Therapeutics Stock Technical Analysis
Fulcrum Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Fulcrum Therapeutics Period Price Range
Low | January 8, 2025
| High |
0.00 | 0.00 |
Fulcrum Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Fulcrum Therapeutics January 8, 2025 Market Strength
Market strength indicators help investors to evaluate how Fulcrum Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Fulcrum Therapeutics shares will generate the highest return on investment. By undertsting and applying Fulcrum Therapeutics stock market strength indicators, traders can identify Fulcrum Therapeutics entry and exit signals to maximize returns
Fulcrum Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Fulcrum Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Fulcrum Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Fulcrum to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0917 | |||
| Jensen Alpha | 0.4496 | |||
| Total Risk Alpha | 0.3517 | |||
| Sortino Ratio | 0.1074 | |||
| Treynor Ratio | 3.95 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Fulcrum Stock analysis
When running Fulcrum Therapeutics' price analysis, check to measure Fulcrum Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fulcrum Therapeutics is operating at the current time. Most of Fulcrum Therapeutics' value examination focuses on studying past and present price action to predict the probability of Fulcrum Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fulcrum Therapeutics' price. Additionally, you may evaluate how the addition of Fulcrum Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Transaction History View history of all your transactions and understand their impact on performance |